Results 181 to 190 of about 1,029,754 (340)

Hydration of portland cement.

open access: bronze, 1914
A.A. Klein, A.J. Phillips
openalex   +1 more source

Reducing formaldehyde emissions and enhancing performance of particleboards through the incorporation of activated carbon produced from Scots pine wood residues

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Wood‐based composite boards present a problem due to formaldehyde emissions from engineered particleboard, which pose health and environmental risks. This study explored the production of activated carbon (AC) from Scots pine (Pinus sylvestris) wood residues using phosphoric acid (H3PO4) as a chemical activator.
Mehmet Emin Ergun   +3 more
wiley   +1 more source

The origins of American industrial success: Evidence from the US portland cement industry [PDF]

open access: yes
The contributions of innovations, factor endowments and institutions to American industrialization are examined through analysing the rise of the American portland cement industry.
Prentice, David
core   +1 more source

Flexible cement fibers with high toughness and water-activated setting behavior for construction. [PDF]

open access: yesNat Commun
Zhu K   +11 more
europepmc   +1 more source

Minor constituents in portland cement clinker

open access: bronze, 1938
Herbert Insley, Howard F. McMurdie
openalex   +1 more source

Biochar in the circular bioeconomy: a bibliometric analysis of technologies, applications, and trends

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biochar has attracted considerable attention in recent years for its wide‐ranging applications, particularly its role in carbon sequestration as a strategy to mitigate greenhouse gas emissions. Its emerging uses within the circular bioeconomy also position it as a valuable tool for environmental management, and ongoing research continues to ...
Jean Agustin Velasquez‐Pinas   +6 more
wiley   +1 more source

Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase‐1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Dipeptidyl peptidase‐1 (DPP‐1) inhibitors have been studied for the treatment of neutrophil‐mediated inflammatory diseases including bronchiectasis, bronchial asthma and cystic fibrosis. This study evaluated the pharmacokinetics, pharmacodynamics, safety and tolerability of DPP‐1 inhibitor HSK31858 in healthy Chinese volunteers.
Yuhao Wang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy